Skip to main content

Table 3 Summary of evidence to support the effectiveness of AIT

From: Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

Study ID

SLIT

SCIT

Calderon et al. [25]

NA

+++

Di Bona et al. [27]

+/−

NA

Di Bona et al. [26]

+/−

NA

Dranitsaris et al. [37]

++ (indirect analysis)

NA

Dretzke et al. [36]

+++

+++

Erekosima et al. [22]

NA

++/+++

Feng et al. [23]

NA

–

Kim et al. [35]

++

++

Lin et al. [28]

++

NA

Meadows et al. [34]

++ (only in adults)

++ (only in adults)

Purkey et al. [24]

NA

+++

Radulovic et al. [29]

++/+++

NA

Röder et al. [38] a

–

–

Sopo et al. [32]

+/++

NA

Wilson et al. [31]

++ (only in adults)

NA

Zhang (2014)

++ (MS)/− (SS)

NA

  1. Effectiveness is overall referred to symptom and medication scores unless otherwise stated
  2. +++, Strong evidence; ++, Moderate evidence; +, Some/limited evidence; +/−, Unclear evidence; –, No evidence; SS, symptom scores; MS, medication scores
  3. aSame results were referred also to oral immunotherapy and intranasal immunotherapy